Pharmacometrica, Longcol, La Fouillade, France
President and founder of PharmacoMetrica France, a company offering global consulting services in Pharmacometrics, and Adjunct Professor, Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chappel Hill, NC. He was the former head of Pharmacometrics at GlaxoSmithKline R&D, King of Prussia, PA (USA). He obtained a degree in Mathematics from the University of Milano (Italy), a PhD in Pharmacokinetics and HDR from the University of Montpellier I (France). He is responsible for strategic and leveraged utilisation of model-based approach for improving efficiency in drug development projects (from lead optimisation to marketing). His current research interests are focused on the identification and on the implementation of strategies based on model-based approach to enhance drug development process, drive decision making and risk management using drug and disease progression models, clinical trial simulation, Bayesian modelling and knowledge-based computer-assisted drug development processes. He is an author of more than 165 original research papers published in international scientific journals on individual and population PK/PD analysis and mathematical modelling in drug discovery, pre-clinical and clinical pharmacology.
Biostatistics, Data Analysis, SAS, Data Management, Clinical Development
Journal of Biometrics & Biostatistics received 3254 citations as per Google Scholar report